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Maintaining active growth and effective immune responses is
often costly for a living organism to survive. Fine-tuning the shared
cross-regulators is crucial for metazoans and plants to make
a trade-off between growth and immunity. The Arabidopsis regu-
latory receptor-like kinase BAK1 complexes with the receptor
kinases FLS2 in bacterial flagellin-triggered immunity and BRI1 in
brassinosteroid (BR)-mediated growth. BR homeostasis and signal-
ing unidirectionally modulate FLS2-mediated immune responses at
multiple levels. We have shown previously that BIK1, a receptor-
like cytoplasmic kinase, is directly phosphorylated by BAK1 and
associates with FLS2/BAK1 complex in transducing flagellin signal-
ing. In contrast to its positive role in plant immunity, we report
here that BIK1 acts as a negative regulator in BR signaling. The
bik1mutant displays various BR hypersensitive phenotypes accom-
panied with increased accumulation of de-phosphorylated BES1
proteins and transcriptional regulation of BZR1 and BES1 target
genes. BIK1 associates with BRI1, and is released from BRI1 receptor
upon BR treatment, which is reminiscent of FLS2-BIK1 complex dy-
namics in flagellin signaling. The ligand-induced release of BIK1
from receptor complexes is associated with BIK1 phosphorylation.
However, in contrast to BAK1-dependent FLS2-BIK1 dissociation,
BAK1 is dispensable for BRI1-BIK1 dissociation. Unlike FLS2 signal-
ing which depends on BAK1 to phosphorylate BIK1, BRI1 directly
phosphorylates BIK1 to transduce BR signaling. Thus, BIK1 relays
the signaling in plant immunity and BR-mediated growth via dis-
tinct phosphorylation by BAK1 and BRI1, respectively. Our studies
indicate that BIK1 mediates inverse functions in plant immunity
and development via dynamic association with specific receptor
complexes and differential phosphorylation events.
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Metazoans and plants have evolved complex mechanisms tocope with the constant challenges of environmental stresses
while maintaining their growth and development. Being sessile
and lacking a sophisticated adaptive immune system, plants possess
a large number of receptor-like kinases (RLKs) and receptor-like
cytoplasmic kinases (RLCKs) that modulate growth, development,
and innate immunity (1). RLKs sense different extrinsic and in-
trinsic cues through the extracellular domain and mediate diverse
signaling events via the kinase domain. Arabidopsis Brassinosteroid
Insensitive 1 (BRI1), a leucine-rich repeat (LRR)-receptor kinase
perceives the polyhydroxylated growth hormones brassinosteroids
(BR) to regulate plant growth and development (2). Despite
structural similarity with BRI1, Flagellin Sensing 2 (FLS2) and EF-
Tu Receptor (EFR) recognize microbe-associated molecular pat-
tern (MAMP) flagellin and elongation factor Tu (EF-Tu), re-
spectively, and initiate innate immune signaling to defend against
pathogen attacks (3, 4). Apparently, signaling specificity is achieved
by specific receptor–ligand interaction. Instead of ligand percep-
tion, RLCKs without an apparent extracellular domain often
complex with RLKs and relay the signaling via phosphorylation.
In BR signaling, BRI1 receptor directly binds to brassinolide
(BL), the most active form of BRs, via a surface pocket embedded
in a 70-aa island of LRR ectodomain. Subsequent heterodimer-
ization, reciprocal and sequential phosphorylation of BRI1 and
BAK1 (BRI1-associated kinase 1), accompanied with release of
the BRI1 C-terminal inhibitory effect and BRI1 Kinase Inhibitor
protein, have been proposed to fully activate BRI1 (5-7). The
activated BRI1 phosphorylates downstream RLCKs BR-Signaling
Kinases (BSKs) and Constitutive Differential Growth 1 (CDG1),
which further interact with and phosphorylate the phosphatase bri1
Suppressor 1 (BSU1) (8, 9). The phosphorylated BSU1 induces
dephosphorylation and inactivation of Brassinosteroid Insensitive
2 (BIN2), a glycogen synthase kinase 3 (GSK3)-like kinase, leading
to the nuclear accumulation of two dephosphorylated transcription
factors Brassinazole-Resistant 1 (BRZ1) and bri1-Ems-Suppressor
1 (BES1) for the regulation of BR-responsive genes (9–11).
In immune signaling, the flagellin receptor FLS2 or EF-Tu
receptor EFR instantaneously forms a ligand-induced complex
with BAK1 and concomitant transphosphorylation events likely
constitute key initial steps in signal transduction (12–14). The
plasma membrane-associated RLCK Botrytis-Induced Kinase 1
(BIK1) associates with FLS2/EFR and BAK1 and is directly
phosphorylated by BAK1 (15-16). BIK1 dissociates from FLS2 in
a BAK1-dependent manner on flagellin perception. BIK1 posi-
tively regulates plant innate immunity, and the bik1 mutant was
compromised in diverse flagellin-mediated responses and im-
munity to nonpathogenic bacterial infection. Activation of MAP
kinases and calcium-dependent protein kinases, two independent
intracellular signaling pathways downstream of the MAMP re-
ceptor complex, governs the expression of MAMP-responsive
genes (17). In addition, MAMP perception leads to ion fluxes,
production of reactive oxygen species (ROS), deposition of cal-
lose, and stomatal closure to prevent pathogen entry (18). Once
activated, immune signaling is subjected to down-regulation to
prevent excessive or prolonged activation of immune responses.
Two plant E3 ubiquitin ligases, PUB12 and PUB13, directly
ubiquitinate FLS2 and promote flagellin-induced FLS2 degra-
dation, which, in turn, attenuates FLS2 signaling (19).
Despite distinct signaling outcomes, BAK1 is a shared compo-
nent in BR and multiple immune signaling via heterodimeriza-
tion with corresponding receptors BRI1, and immune receptors,
such as FLS2 and EFR (12–14, 20, 21). BAK1 is also known as
somatic embryogenesis receptor kinase (SERK) 3, belonging to
a subfamily of RLKs with five members, SERK1 to SERK5 (22).
In addition to BAK1/SERK3, BRI1 also associates with SERK1
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and SERK4/BKK1 (BAK1-like 1) that play partially redundant
roles with BAK1 in BR signaling (23–25). Similarly, BAK1 and
SERK4 also exhibit redundant functions in plant innate immu-
nity via association with multiple MAMP receptors (14). Recent
studies have shown that BR homeostasis and signaling unidi-
rectionally modulate FLS2-mediated immune responses (26, 27).
The essential role of BAK1 in both BR and flagellin signaling
pathways suggests that it may function as a rate-limiting factor
to make a tradeoff between growth and immunity. Interestingly,
BR antagonizes FLS2 signaling in both BAK1-dependent and
BAK1-independent manners. To date, signaling components
downstream of BAK1 appear to be divergent in FLS2 and BRI1
pathways. Here, we found that BIK1, a positive regulator in plant
immunity, acts as a negative regulator in BR signaling. In con-
trast to its compromised immune responses, the bik1 mutant
displays various BR hypersensitive phenotypes, including en-
hanced hypocotyl length of dark-grown seedlings and root
growth inhibition upon BL treatment. The bik1 mutant also
exhibits increased accumulation of dephosphorylated BES1 and
expression of BZR1 and BES1 target genes. BIK1 interacts with
BRI1 at low BR concentration and releases from BRI1 upon
exogenous BL treatment in a kinase-dependent manner. Unlike
BIK1-FLS2 dissociation, which is BAK1 dependent, the BIK1-
BRI1 dissociation is independent of BAK1. Apparently, release
of BIK1 from receptor complexes is a result of BIK1 phos-
phorylation upon signal perception. In FLS2 signaling, BAK1 is
crucial for flagellin-mediated BIK1 phosphorylation and com-
plex dissociation. However, in BR signaling, BRI1 is able to
phosphorylate BIK1 directly and the phosphorylation event was
further enhanced upon BL treatment.
Results
The bik1 Mutant Confers Hypersensitivity to Brassinolide. Given the
observation that the bik1 mutant plants exhibit slightly reduced
primary root elongation, early flowering, and reduced fertility
(28), it is likely that BIK1 is involved in plant growth and de-
velopment. In addition, the bik1 mutant plants have moderately
elongated and curling petioles, which were often observed in
BRI1 overexpressing plants (Fig. S1) or mutants with constitutive
activation of BR signaling (29). BIK1 is a direct phosphorylation
target of BAK1, an important component in BR signaling, and
BIK1 transphosphorylates BAK1 to enhance BAK1 kinase ac-
tivity (15). These observations prompted us to examine the po-
tential involvement of BIK1 in BR signaling.
BAK1 positively regulates BR signaling by transphosphorylation
of the BRI1 receptor (5, 20, 21). Surprisingly, in contrast to bak1-4
mutant, which is partially insensitive to BL treatment, bik1 mutant
displays constitutive BR responses and are hypersensitive to BL
treatment. When grown in the dark, the hypocotyls of bik1 mutant
elongated slightly, but were significantly longer than those of wild-
type (WT) plants, whereas bak1-4mutant exhibited relatively short
hypocotyls (Fig. 1 A and B, Lower). In the presence of brassinazole
(BRZ), an inhibitor of BR biosynthesis, the bik1 mutant displayed
much more pronounced hypocotyl elongation than WT plants
(Fig. 1 A and B, Upper), suggesting that the bik1 mutant was less
sensitive to BRZ treatment. The treatment of BL increases hy-
pocotyl elongation and inhibits root growth of WT plant seedlings
grown under the light. Consistent with its positive role in BR sig-
naling, bak1-4 mutant was partially insensitive to BL treatment
(Fig. 1 C and D). However, the bik1 mutant was hypersensitive to
BL treatment with elevated root growth inhibition and hypocotyl
elongation compared with WT seedlings (Fig. 1 C and D).
To confirm that the phenotypes observed in the bik1 mutant
were attributed to the mutation in BIK1, we complemented the
bik1 mutant with the BIK1 cDNA under the control of its native
promoter. The BIK1 transgene rescued bik1 mutant phenotypes
in response to BRZ treatment (Fig. 1E). Interestingly, we ob-
served that the bik1 mutant exhibited twisted hypocotyls when
grown in the dark (Fig. S2). This phenotype is likely due to the
constitutive activation of BR signaling in the bik1 mutant be-
cause the treatment of BL induced bik1-like hypocotyl twisting in
the WT, but not bri1-5 seedlings (Fig. S2). The BL treatment
further accelerated the hypocotyl twisting in the bik1 mutant,
consistent with our observation that the bik1 mutant was hy-
persensitive to BL treatment. As expected, the BR biosynthesis
mutant de-etiolated2 (det2) still responded to BL treatment to
induce hypocotyl twisting (Fig. S2). In addition, the exogenously
prolonged application of BRZ in the growth medium retarded
the seedling growth and development likely due to the largely
reduced BR biosynthesis (Fig. S3). Compared with WT plants,
the bik1 mutant substantially ameliorated the BRZ-mediated
growth inhibition (Fig. S3). Together, the data suggest that the
loss of BIK1 activated BR signaling.
The bik1 mutant plants have elevated salicylic acid (SA) ac-
cumulation compared with WT plants (28). To investigate
whether the high level of SA attributes to the observed BR
phenotypes in the bik1mutant, we examined the BR responses in
the bik1sid2 double mutant, in which the high SA level is di-
minished by a SA biosynthesis mutant sid2 (30). Similar to the
bik1 mutant, the bik1sid2 mutant exhibited elongated hypocotyls
in the absence or presence of BRZ when grown in the dark and
displayed hypersensitivity to BL treatment with elevated hypo-
cotyl elongation and root inhibition when grown under the light
(Fig. S4). The dark grown bik1sid2 double mutant also showed
twisted hypocotyls in the absence of BL treatment and BL
treatment exacerbated the phenotype (Fig. S2). The data suggest
that BR hypersensitivity in the bik1 mutant was unlikely caused
by the high level of SA.
BIK1 Negatively Regulates BR Signaling. The elicitation of BR sig-
naling induces dephosphorylation of two closely related tran-
scription factors, BES1 and BZR1, which in turn regulate the
Fig. 1. Elevated BR responses in bik1 mutant
plants. (A) The bik1mutant is partially insensitive to
BRZ treatment. The seedlings of WT (Col-0), bak1-4,
and bik1mutants were grown in the dark for 8 d on
1/2 MS plates with or without 2 μM BRZ. (B)
Quantification of hypocotyl length shown in A. (C)
The bik1 mutant is hypersensitive to BL treatment.
The seedlings were grown on 1/2 MS plates with or
without 100 nM BL under the constant light for 14 d.
(D) Quantification of root and hypocotyl length
shown in C. The data are shown as mean ± SE from
at least 25 seedlings. Asterisk indicates a significant
difference with P < 0.05 compared with data from
WT seedlings. (E) BIK1 complementation lines re-
store the BRZ insensitivity of the bik1 mutant. The
above experiments were repeated three to four
times with similar results.
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expression of BR target genes including brassinosteroid-6-oxidase
(BR6OX), constitutive photomorphogenic dwarf (CPD), and
dwarf 4 (DWF) (31, 32). We examined the phosphorylation status
of endogenous BES1 proteins with a specific α-BES1 antibody. In
WT seedlings, the BL treatment induced BES1 dephosphorylation
as indicated with the mobility shift of BES1 proteins from high
molecular weight to low molecular weight in Western blot.
Compared with WT plants, the bik1 mutant exhibited an elevated
amount of dephosphorylated BES1 protein either with or without
BL treatment (Fig. 2A). Apparently, both phosphorylated and
dephosphorylated forms of BES1 proteins accumulated more in
the bik1 mutant than those in WT plants (Fig. 2A).
Down-regulation of BR biosynthesis genes BR6OX, CPD, and
DWF4 constitutes a negative feedback regulation mechanism in
response to BR treatment or situations of enhanced BR signal-
ing. Consistent with this notion, the expression of BR6OX, CPD,
and DWF4 was significantly lower in the 10-d-old bik1 seedlings
than that in WT before BL treatment, and the expression was
further reduced in the bik1 mutant compared with WT plants
upon BL treatment (Fig. 2B). We also investigated whether the
activation of BR signaling in the bik1 mutant was specific to
a plant developmental stage. Similar reduction of BR6OX, CPD,
and DWF4 gene expression was observed in the 4-wk-old bik1
mutant plants compared with WT plants (Fig. S5). Thus, BIK1
negatively regulates BR signaling upstream of BES1 phosphor-
ylation in both seedlings and mature plants.
BIK1 Associates with BRI1. BIK1 is a plasma membrane localized
protein with a putative myristoylation motif (28). In flagellin sig-
naling, BIK1 associates with both FLS2 and BAK1 (15, 16). To
examine whether BIK1 forms a complex with BRI1, we performed
coimmunoprecipitation (Co-IP) assays by coexpressing FLAG
epitope-tagged BIK1 and HA epitope-tagged BRI1 in protoplasts.
As shown in Fig. 3A, BIK1 coimmunoprecipitated BRI1 in vivo
(Fig. 3A). Interestingly, the association of BIK1 with BRI1 appears
to be reduced upon BL treatment (Fig. 3A), suggesting that BIK1
might be released from the receptor complex upon BL perception.
We further confirmed BIK1 and BRI1 association in the pBIK1::
BIK1-HA/pBRI1::BRI1-GFP transgenic plants. As shown in Fig.
3B, BIK1-HA coimmunoprecipitated BRI1-GFP as detected with
α-GFP antibody upon α-HA antibody immunoprecipitation. Con-
sistently, bimolecular fluorescence complementation (BiFC) assay
also indicated that BRI1 associates with BIK1 with cotransfection
of BIK1 fused to the carboxyl-terminal half of YFP (yellow fluo-
rescence protein) (BIK1-cYFP) and BRI1 fused to the amino-ter-
minal half of YFP (BRI1-nYFP) in protoplasts (Fig. S6A). BIK1-
BRI1 association and BL-induced dissociation were also con-
firmed with Nicotiana benthamiana transient assay (Fig. S6B). To
test whether BRI1 directly interacts with BIK1 through the cyto-
solic kinase domain, we performed an in vitro pull-down assay
with the BRI1 cytosolic domain (BRI1CD) fused to maltose
binding protein (MBP) immobilized on amylose-agarose beads as
bait against GST-BIK1 fusion proteins. As shown in Fig. 3C, GST-
BIK1 could be pulled down by MBP-BRI1CD, not MBP itself.
Similarly, GST-BRI1CD could be pulled down by MBP-BIK1
(Fig. S6C). Taken together, the data demonstrate that BIK1
functions in BR signaling by direct interaction with BRI1 cy-
tosolic kinase domain.
BL-Induced BRI1 Phosphorylation on BIK1. Because BIK1 interacts
with BRI1, we tested whether BRI1 could directly phosphorylate
BIK1 to transduce BR signaling. An in vitro kinase assay with
GST-BIK1Km (the kinase-inactive mutant) as a substrate indi-
cates that MBP-BRI1CD directly phosphorylated GST-BIK1Km
(Fig. 4A). Interestingly, it appears that MBP-BRI1CD exhibited
stronger kinase activity toward BIK1 than that to BAK1 (Fig.
4A). Phosphorylation of BIK1 by BRI1 was also observed with an
immunocomplex kinase assay in which HA epitope-tagged full-
length BRI1 was expressed in protoplasts, and BRI1 was pulled
down with an α-HA antibody and used in an in vitro kinase assay
by using GST-BIK1Km or GST-BAK1Km as a substrate. The
immunoprecipitated BRI1 phosphorylated BIK1Km (Fig. 4B).
Importantly, BIK1 phosphorylation by BRI1 was enhanced upon
Fig. 2. BIK1 negatively regulates BR signaling. (A) BES1 phosphorylation in
WT and bik1 mutant plants. The phosphorylated (pBES1) and dephosphory-
lated BES1 proteins were detected with an α-BES1 antibody (Upper). Equal
loading was ensured by total protein quantification before loading and by
Coomassie brilliant blue staining (CBS) of the membrane (Lower). The band
intensity was quantified by ImageJ software and labeled under the gel. (B)
Expression of BR responsive genes with qRT-PCR analysis. Ten-day-old seed-
lings were treated with 2 μMBL or H2O for 2 h. The expression of BR6OX, CPD,
or DWF4 was normalized to the expression of UBQ10. The data are shown as
mean ± SE from three independent biology repeats. Asterisk indicates a sig-
nificant difference with P < 0.05 compared with data from WT seedlings. The
above experiments were repeated three times with similar results.
Fig. 3. BIK1 associates with BRI1. (A) BIK1 associates with BRI1 in proto-
plasts. BIK1-FLAG was coexpressed with BRI1-HA in Arabidopsis protoplasts.
Co-IP was carried out with an α-FLAG antibody (IP: α-FLAG), and the proteins
were analyzed by using Western blot with α-HA antibody. Top shows that
BIK1-FLAG coimmunoprecipitated with BRI1-HA (IP: α-FLAG; WB: α-HA).
Middle and Bottom show the expression of BRI1-HA and BIK1-FLAG proteins
(WB: α-HA or α-FLAG for input control). Protoplasts were treated with 2 μM
BL for 2 h. (B) BIK1 associates with BRI1 in transgenic plants. The membrane
proteins from 4-wk-old pBIK1::BIK1-HA/pBRI1::BRI1-GFP (#6 and #9) or
pBRI1::BRI1-GFP plants were immunoprecipitated with α-HA antibody and
analyzed with Western blot using α-GFP antibody (Top). The expression of
BRI1-GFP and BIK1-HA in transgenic plants are shown (Middle and Bottom).
(C) BIK1 interacts with BRI1 cytosolic domain in vitro. GST-BIK1 proteins were
incubated with MBP or MBP-BRI1CD beads (PD:MBP), and the beads were
collected and washed for Western blot of immunoprecipitated proteins with
α-GST antibody. Asterisk indicates nonspecific bands. The above experiments
were repeated three times with similar results.
12116 | www.pnas.org/cgi/doi/10.1073/pnas.1302154110 Lin et al.
BRI1 activation with BL treatment (Fig. 4B). BL treatment did
not induce BIK1 phosphorylation by BRI1Km (Fig. S6D). The BL
treatment also enhanced BRI1 phosphorylation on BAK1Km,
which was used as a control (Fig. 4B). BL-induced BIK1 phos-
phorylation by BRI1 was further detected by an α-pThr antibody
with coexpressing BRI1 and BIK1 in protoplasts (Fig. S6E). The
data indicate that BIK1 is a direct substrate of BRI1 and BL
induces BRI1 phosphorylation on BIK1.
The 22-aa peptide of flagellin (flg22) treatment induces rapid
BIK1 phosphorylation as indicated by a mobility shift of the pro-
tein on SDS/PAGE (Fig. S7A) (15, 16). We did not observe the
clear and reproducible mobility shift of BIK1 upon BL treatment
although we modified the SDS/PAGE gels with various ratios of
bisacrylamide to acrylamide, which offers better separation of
different phosphorylation states for phosphoproteins (Fig. S7A).
The data suggest that the phosphorylation change of BIK1 medi-
ated by BR might be distinct from that triggered by flagellin.
However, when coexpressing with BRI1, the mobility shift of BIK1
was observed upon BL treatment (Fig. S7B), suggesting BRI1
phosphorylates BIK1 in vivo in BR signaling.
Differential Requirement of BAK1 for BIK1-FLS2 and BIK1-BRI1
Dissociation. Because BRI1 interacts with and phosphorylates
BIK1, we tested whether the kinase activity is required for their
interaction. We coexpressed BIK1Km-GFP with BRI1-HA in
protoplasts for Co-IP assay. As shown in Fig. 4C, BIK1Km-GFP
coimmunoprecipitated BRI1-HA in vivo. However, the BL-induced
BIK1-BRI1 dissociation was no longer observed with BIK1Km
(Fig. 4C). Similarly, BIK1 still interacts with BRI1Km, and this
interaction was not reduced upon BL treatment (Fig. 4D). Thus,
the kinase activity of BIK1 and BRI1 is not required for their in-
teraction, whereas it is indispensable for BL-induced BIK1-BRI1
dissociation. Apparently, release of BIK1 from BRI1 receptor
complex upon BL-induced phosphorylation is one of early steps in
transducing BR signaling.
BL-induced BIK1-BRI1 dissociation is strikingly similar with
the dynamics of BIK1–FLS2 complex formation upon flagellin
perception (15, 16). BIK1 constitutively interacts with FLS2 in
the absence of flagellin, whereas the interaction was reduced
upon treatment by flg22 (Fig. S7C). In FLS2 signaling, BAK1 is
essential for flg22-induced BIK1 phosphorylation and BAK1
directly phosphorylates BIK1 in vitro, whereas FLS2 has little
kinase activity (15, 16). Consistently, BAK1 is indispensible for
flg22-induced BIK1-FLS2 dissociation because flg22 treatment
no longer reduces BIK1-FLS2 association in bak1-4 mutant (Fig.
4E). These results support that phosphorylation of BIK1 by
BAK1 upon flg22 perception leads to its dissociation from FLS2
receptor complex and, thereby, transducing intracellular FLS2
signaling. In contrast, BL-induced BIK1-BRI1 dissociation still
occurred in the bak1-4 mutant (Fig. 4F), indicating that BAK1 is
unlikely essential for BIK1 release from the BRI1 receptor in BR
signaling. It is also possible that other SERK family members
have redundant function with BAK1 for BIK1 release from the
receptor complex (25). Consistent with the direct phosphoryla-
tion of BIK1 by BRI1, the BRI1 immunoprecipitated from bak1-4
mutant was still able to phosphorylate BIK1 in vitro (Fig. S7D).
Considering that BIK1-BRI1 dissociation is a result of BIK1
phosphorylation and BRI1 phosphorylates BIK1, it is likely that
BAK1 plays little direct role in BIK1 phosphorylation in BR
signaling. Thus, BRI1 is able to directly phosphorylate BIK1 to
transduce BR signaling, whereas BAK1 is essential to phos-
phorylate BIK1 in transducing flg22 signaling.
BIK1 Acts Downstream of BRI1 in BR Signaling. Our phenotypic,
molecular, and biochemical data suggested that BIK1 negatively
regulates BR signaling via association and phosphorylation by
BRI1. We further investigated whether BRI1 functions geneti-
cally upstream of BIK1 by crossing the bik1 mutant with bri1-5 or
bri1-119 mutant to generate the bik1bri1-5 and bik1bri1-119
double mutants. As shown in Fig. 5A, the bik1bri1-5 and bik1bri1-
119 double mutants partially rescued the growth deficiency in the
bri1 mutant. The double mutants displayed reduced growth
dwarfism, enlarged leave size, and elongated inflorescence stems
and branches compared with the bri1-5 or bri1-119 single mutant
(Fig. 5A). Notably, the double mutants still exhibited the defects
in silique development and had reduced seed yield, likely con-
tributed by the mutation in BIK1 (Fig. S8) (28). The double
mutant phenotype was unlikely caused by crossing of two dif-
ferent Arabidopsis ecotypes (24). The bik1det2-1 double mutant
also partially suppressed the dwarf phenotype of det2 (Fig. 5A).
Consistently, the hypocotyls of dark-grown bik1bri1-5 and bik1-
bri1-119 seedlings were longer than those of corresponding single
Fig. 4. BL-induced BIK1 phosphorylation by BRI1. (A) BRI1
phosphorylates BIK1 in vitro. An in vitro kinase assay was
performed by incubating MBP-BRI1CD with GST, GST-BIK1Km,
or GST-BAK1Km proteins. Proteins were separated by 10% SDS/
PAGE and analyzed by autoradiography (Upper), and the
protein loading control was shown by CBS (Lower). (B) BL
treatment enhances BRI1 phosphorylation on BIK1. BRI1-HA
was expressed in WT protoplasts for 10 h followed by 2 μM BL
treatment for 2 h. BRI1-HA proteins were immunoprecipitated
with α-HA antibody and subjected to an in vitro kinase assay
with GST-BIK1Km or GST-BAK1Km proteins as substrates (Top).
Middle shows the BRI1-HA expression, and Bottom shows GST-
BIK1Km and GST-BAK1Km proteins. (C) BIK1Km-BRI1 associa-
tion in protoplasts. Protoplasts were treated with 2 μM BL for
2 h. (D) BIK1-BRI1Km association in protoplasts. (E) BAK1 is
required for flg22-induced BIK1-FLS2 dissociation. The BIK1–
FLS2 interaction was performed with bak1-4 protoplasts. Pro-
toplasts were treated with 1 μM flg22 for 15 min. (F) BAK1 is
not required for BL-induced BIK1-BRI1 dissociation. The BIK1–
BRI1 interaction was performed with bak1-4 protoplasts. Pro-
toplasts were treated with 2 μM BL for 2 h. The above
experiments were repeated three times with similar results.
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mutants (Fig. 5B). Under the light, bik1bri1-5 and bik1bri1-119
seedlings also partially restored the leaf growth and hypocotyl
length of the single mutants (Fig. 5C). These results suggest that
BIK1 genetically interacts with BRI1 and inhibits BR signaling
in vivo.
Discussion
BIK1 was originally identified as Botrytis-induced kinase and plays
critical roles in mediating plant resistance to necrotrophic fungal
pathogens (28). We and others have shown that BIK1 is rapidly
phosphorylated upon bacterial flagellin perception and associates
with flagellin receptor complex in transducing plant immune
signaling (15, 16). BIK1 is a direct substrate of BAK1, a shared
regulatory component of multiple MAMP receptors and plant
hormone BR receptor BRI1. Consistent with this notion, BIK1 is
involved in immune signaling triggered by multiple MAMPs likely
through association with the corresponding receptors. BIK1 is
also phosphorylated upon ethylene treatment and required for
responses to ethylene (30). Surprisingly, in this study, our exten-
sive phenotypic, genetic, and biochemical examination of bik1
mutant revealed that in contrast to its positive roles in plant
immune and ethylene signaling, BIK1 negatively regulates BR-
mediated responses and signaling. BIK1 complexes with BRI1
and dissociates from the BRI1 complex upon BL perception,
likely as a result of BIK1 phosphorylation by BRI1. Intriguingly,
BAK1 is required for flagellin-induced BIK1 release from FLS2,
but not for BL-induced BIK1 release from BRI1. Consistent with
the data that FLS2 is a non–arginine-aspartate (RD) kinase with
little kinase activity whereas BRI1 is an RD kinase with strong
kinase activity (5), we observed a direct phosphorylation of BIK1
by BRI1, not by FLS2. Thus, BIK1 relays flagellin signaling via
BAK1-mediated phosphorylation, whereas BIK1 is directly
phosphorylated by BRI1 in transducing BR signaling (Fig. S9).
Differential phosphorylation of BIK1 by BAK1 and BRI1 may
determine the substrate specificity and signaling outcomes.
Identification of the in vivo phosphorylation sites of BIK1 and
characterization of their functional requirement in BR- and fla-
gellin-mediated responses will shed light on how BIK1 positively
regulates flagellin signaling but negatively controls BR signaling.
Several other members of the RLCKs, including BSKs from
subfamily XII and CDG1 from subfamily VIIc have been iden-
tified as signaling components in transducing BR signaling via
association with BR receptor BRI1 (8, 9). Similar to BIK1, BSKs
associate with BRI1 and are released from the BRI1 complex
upon BR perception. However, unlike BIK1, BSKs and CDG1
play positive roles in BR signaling. CDG1 directly phosphor-
ylates BSU1, a phosphatase that dephosphorylates the negative
regulator BIN2 (9). Phosphorylation of BSK1 by BRI1 promotes
BSK1 binding to BSU1, which inactivates BIN2 kinase activity
(33). Moreover, BSKs and CDG1 differ from BIK1 in that BSKs
and CDG1 associate only with BRI1 and are phosphorylated by
BRI1, not by BAK1. In contrast, BIK1 associates with both BRI1
and BAK1 and is phosphorylated by BRI1 and BAK1. Appar-
ently, BIK1–BAK1 interaction and phosphorylation are more
involved in flagellin signaling than that in BR signaling. Similar
with BSKs and CDG1, BR-mediated BIK1 phosphorylation and
BRI1-BIK1 dissociation are independent of BAK1. This result
suggests the similarity and distinction of individual RLCKs in
mediating different plant signaling pathways.
Our data indicate that the bik1mutant possesses enhanced BR
signaling. It has been shown that BR homeostasis and signaling
antagonize flg22-induced responses (26, 27). One question is
whether the compromised immune responses in the bik1 mutant
are attributed to the elevated BR signaling. Accumulating evi-
dence argues against this possibility. First, although exogenous
application of BL inhibited certain FLS2- and EFR-mediated
responses (26), it has not been reported that BR could promote
disease symptom development or bacterial multiplication in
Arabidopsis. In contrast, tobacco plants treated with BL
exhibited enhanced resistance to multiple pathogens, including
Pseudomonas bacteria (34). Besides compromised flg22-induced
ROS production and defense gene activation, the bik1 mutant
plants are also deficient in resistance to nonpathogenic bacterial
infection and flg22-mediated restriction of bacterial growth (15,
16). Second, elevated BR signaling is not directly correlated
with compromised immune responses. Although plants over-
expressing BRI1 blocked FLS2- and EFR-mediated responses,
BRI1sud1 plants with normal BRI1 protein level, but increased
BRI1 signaling, display enhanced flg22-induced signaling (27).
It has been proposed that the increased levels of BRI1, not
increased BR signaling in BRI1 overexpressing plants, contrib-
ute to the antagonistic effects on MAMP signaling. We did not
detect the reproducible difference of BRI1 protein level in WT
and bik1 mutant, suggesting that enhanced BR signaling in bik1
mutant is not caused by overproduction of BRI1 receptor.
Third, BR treatment did not affect flg22-mediated BIK1 phos-
phorylation (26). BIK1 phosphorylation is one of the earliest
steps in flagellin signaling. Thus, the antagonistic effects on
MAMP signaling by BL treatment are not due to the reduced
BIK1 phosphorylation and activity. Together, the functions of
BIK1 in flg22 and BR signaling are mechanistically uncoupled
Fig. 5. BIK1 acts downstream of BRI1 in BR signaling. (A) The bik1bri1-5,
bik1bri1-119, and bik1det2-1 double mutants partially rescued the growth
deficiency of single mutants. The phenotypes of 4-wk-old (Upper) and 8-wk-
old (Lower) soil-grown plants are shown. (B) The hypocotyls of dark-grown
bik1bri1-5 and bik1bri1-119 seedlings were longer than those of single
mutants. Representatives of 8-d-old seedlings grown in the dark are shown
on Left, and the quantification of hypocotyl length is shown on Right. The
data are shown as mean ± SE from at least 25 seedlings. Asterisk indicates
a significant difference with P < 0.05 compared with data from the corre-
sponding single mutants. (C) The bik1bri1-5 and bik1bri1-119 seedlings
partially restored the leave growth and hypocotyl length of single mutants
grown under the light. Representatives of 14-d-old seedlings under the
constant light are shown on Left, and the quantification of hypocotyl length
is shown on Right.
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and the compromised immune responses in the bik1 mutant are
not simply due to the elevated BR signaling.
Experimental Procedures
Plant Materials and Growth Conditions. The bik1, sid2, bak1-4, and bik1sid2
mutants were reported (15, 30). The bri1-119 and det2-1 were obtained
from the Arabidopsis Biological Resource Center. The bri1-5 mutant was
obtained from Y. Yin (Ames, IA). The bik1bri1-5, bik1bri1-119, bik1det2-1
double mutants were generated by genetic crosses and confirmed by gen-
otyping. Arabidopsis plants were grown in soil (Metro Mix 360) in a growth
room at 23 °C, 60% relative humidity, and 75 μE m−2·s−1 light with a 12-h
photoperiod for approximate 4 wk before protoplast isolations or RNA
isolations. To grow Arabidopsis seedlings, the seeds were surface sterilized
with 50% (vol/vol) bleach for 10 min, and then placed on the plates with 1/2
MS medium containing 0.5% sucrose, 0.8% agar, and 2.5 mMMES at pH 5.7.
For various BR response assays, 100 nM BL (Chemiclones) or 2 μM BRZ (TCI
America) were added in the medium. At least 25 seedlings were measured
for each genotype and each treatment. All experiments were repeated three
to four times, and the representative data were shown in the figures.
Plasmid Construction and Generation of Transgenic Plants. Arabidopsis FLS2,
BAK1, BAK1km, BIK1, and BIK1km constructs in plant expression vector or
protein expression vector were reported (15). Full-length BRI1 was amplified
by PCR from Col-0 cDNA and cloned into a plant expression vector. Cytosolic
domain of BRI1 was cloned into the modified GST fusion protein expression
vector pGEX4T-1 (Pharmacia) or pMAL-c2 (New England Biolabs). The BIK1
promoter up to 2.5 kb was amplified by PCR from Col-0 genomic DNA and
introduced into pCB302 binary vector carrying BIK1-HA. All of the constructs
were fully sequenced to verify mutations in the gene coding and promoter
region. Stable transgenic lines were generated by using the standard
Agrobacterium tumefaciens-mediated transformation in the pBRI1::BRI1-
GFP transgenic plants or the bik1 mutant plants.
Protein Extraction, Co-IP, Phosphorylation, in Vitro Pull-Down, and Real-Time
RT-PCR Assays. The detailed procedures were described in SI Experimental
Procedures. Briefly, 10-d-old seedlings were used for BES1 protein expres-
sion and 2 × 105 protoplasts or 15 g of leaf samples were used for Co-IP
assays.
ACKNOWLEDGMENTS. We thank the Arabidopsis Biological Resource Cen-
ter, Drs. J. Li and Y. Yin for various Arabidopsis mutants and transgenic
plants, Dr. Y. Yin for generous sharing of α-BES1 antibody, Dr. F. Rolland
for protoplast BiFC vectors, and Dr. T. Devarenne for critical reading of the
manuscript. The work was supported National Institute of Health Grants
R01GM092893, USDA National Institute of Food and Agriculture Grant 2012-
67013-19433 (to P.H.), NIH Grant R01GM097247, National Science Foundation
Grant IOS-1030250, The Robert A. Welch Foundation (A-1795) (to L.S.), and
National Science Foundation of China Grant 30800713 (to Z.W.).
1. Shiu SH, Bleecker AB (2001) Receptor-like kinases from Arabidopsis form a mono-
phyletic gene family related to animal receptor kinases. Proc Natl Acad Sci USA 98(19):
10763–10768.
2. Li J, Chory J (1997) A putative leucine-rich repeat receptor kinase involved in brassi-
nosteroid signal transduction. Cell 90(5):929–938.
3. Gómez-Gómez L, Boller T (2000) FLS2: An LRR receptor-like kinase involved in the
perception of the bacterial elicitor flagellin in Arabidopsis. Mol Cell 5(6):1003–1011.
4. Zipfel C, et al. (2006) Perception of the bacterial PAMP EF-Tu by the receptor EFR
restricts Agrobacterium-mediated transformation. Cell 125(4):749–760.
5. Wang X, et al. (2008) Sequential transphosphorylation of the BRI1/BAK1 receptor
kinase complex impacts early events in brassinosteroid signaling. Dev Cell 15(2):
220–235.
6. Wang X, Chory J (2006) Brassinosteroids regulate dissociation of BKI1, a negative
regulator of BRI1 signaling, from the plasma membrane. Science 313(5790):1118–1122.
7. Wang X, et al. (2005) Autoregulation and homodimerization are involved in the ac-
tivation of the plant steroid receptor BRI1. Dev Cell 8(6):855–865.
8. Tang W, et al. (2008) BSKs mediate signal transduction from the receptor kinase BRI1
in Arabidopsis. Science 321(5888):557–560.
9. Kim TW, Guan S, Burlingame AL, Wang ZY (2011) The CDG1 kinase mediates brassi-
nosteroid signal transduction from BRI1 receptor kinase to BSU1 phosphatase and
GSK3-like kinase BIN2. Mol Cell 43(4):561–571.
10. Li J, Nam KH (2002) Regulation of brassinosteroid signaling by a GSK3/SHAGGY-like
kinase. Science 295(5558):1299–1301.
11. Yin Y, et al. (2002) BES1 accumulates in the nucleus in response to brassinosteroids to
regulate gene expression and promote stem elongation. Cell 109(2):181–191.
12. Heese A, et al. (2007) The receptor-like kinase SERK3/BAK1 is a central regulator of
innate immunity in plants. Proc Natl Acad Sci USA 104(29):12217–12222.
13. Chinchilla D, et al. (2007) A flagellin-induced complex of the receptor FLS2 and BAK1
initiates plant defence. Nature 448(7152):497–500.
14. Roux M, et al. (2011) The Arabidopsis leucine-rich repeat receptor-like kinases BAK1/
SERK3 and BKK1/SERK4 are required for innate immunity to hemibiotrophic and bi-
otrophic pathogens. Plant Cell 23(6):2440–2455.
15. Lu D, et al. (2010) A receptor-like cytoplasmic kinase, BIK1, associates with a flagellin
receptor complex to initiate plant innate immunity. Proc Natl Acad Sci USA 107(1):
496–501.
16. Zhang J, et al. (2010) Receptor-like cytoplasmic kinases integrate signaling from
multiple plant immune receptors and are targeted by a Pseudomonas syringae ef-
fector. Cell Host Microbe 7(4):290–301.
17. Boudsocq M, et al. (2010) Differential innate immune signalling via Ca(2+) sensor
protein kinases. Nature 464(7287):418–422.
18. Schwessinger B, Ronald PC (2012) Plant innate immunity: Perception of conserved
microbial signatures. Annu Rev Plant Biol 63:451–482.
19. Lu D, et al. (2011) Direct ubiquitination of pattern recognition receptor FLS2 at-
tenuates plant innate immunity. Science 332(6036):1439–1442.
20. Nam KH, Li J (2002) BRI1/BAK1, a receptor kinase pair mediating brassinosteroid
signaling. Cell 110(2):203–212.
21. Li J, et al. (2002) BAK1, an Arabidopsis LRR receptor-like protein kinase, interacts with
BRI1 and modulates brassinosteroid signaling. Cell 110(2):213–222.
22. Chinchilla D, Shan L, He P, de Vries S, Kemmerling B (2009) One for all: The receptor-
associated kinase BAK1. Trends Plant Sci 14(10):535–541.
23. He K, et al. (2007) BAK1 and BKK1 regulate brassinosteroid-dependent growth and
brassinosteroid-independent cell-death pathways. Curr Biol 17(13):1109–1115.
24. Karlova R, et al. (2006) The Arabidopsis SOMATIC EMBRYOGENESIS RECEPTOR-LIKE
KINASE1 protein complex includes BRASSINOSTEROID-INSENSITIVE1. Plant Cell 18(3):
626–638.
25. Gou X, et al. (2012) Genetic evidence for an indispensable role of somatic embryo-
genesis receptor kinases in brassinosteroid signaling. PLoS Genet 8(1):e1002452.
26. Albrecht C, et al. (2012) Brassinosteroids inhibit pathogen-associated molecular pat-
tern-triggered immune signaling independent of the receptor kinase BAK1. Proc Natl
Acad Sci USA 109(1):303–308.
27. Belkhadir Y, et al. (2012) Brassinosteroids modulate the efficiency of plant immune
responses to microbe-associated molecular patterns. Proc Natl Acad Sci USA 109(1):
297–302.
28. Veronese P, et al. (2006) The membrane-anchored BOTRYTIS-INDUCED KINASE1 plays
distinct roles in Arabidopsis resistance to necrotrophic and biotrophic pathogens.
Plant Cell 18(1):257–273.
29. Yan Z, Zhao J, Peng P, Chihara RK, Li J (2009) BIN2 functions redundantly with other
Arabidopsis GSK3-like kinases to regulate brassinosteroid signaling. Plant Physiol 150
(2):710–721.
30. Laluk K, et al. (2011) Biochemical and genetic requirements for function of the
immune response regulator BOTRYTIS-INDUCED KINASE1 in plant growth, ethyl-
ene signaling, and PAMP-triggered immunity in Arabidopsis. Plant Cell 23(8):
2831–2849.
31. Sun Y, et al. (2010) Integration of brassinosteroid signal transduction with the
transcription network for plant growth regulation in Arabidopsis. Dev Cell 19(5):
765–777.
32. Yu X, et al. (2011) A brassinosteroid transcriptional network revealed by genome-
wide identification of BESI target genes in Arabidopsis thaliana. Plant J 65(4):
634–646.
33. Kim TW, et al. (2009) Brassinosteroid signal transduction from cell-surface receptor
kinases to nuclear transcription factors. Nat Cell Biol 11(10):1254–1260.
34. Nakashita H, et al. (2003) Brassinosteroid functions in a broad range of disease re-
sistance in tobacco and rice. Plant J 33(5):887–898.
Lin et al. PNAS | July 16, 2013 | vol. 110 | no. 29 | 12119
PL
A
N
T
BI
O
LO
G
Y
